ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Deciphera Announces Positive Results from Ripretinib Study americanpharmaceuticalreview
August 14, 2019Deciphera Pharmaceuticals announced positive top-line data from the INVICTUS pivotal Phase 3 clinical study of ripretinib, a broad-spectrum KIT and PDGFRα inhibitor, in patients with fourth-line and fourth-line plus gastrointestinal stromal tumors (GIST).
Pharma Sources Insight January 2025
